Table 4.
Cytotoxicity activities (IC50) of AgNPs against hepatocellular cancer (HepG-2) and breast cancer cells (MCF-7).
Cell Lines | IC50 µg/mL | |
---|---|---|
AgNPs | Doxorubicin | |
HepG2 | 7.6 | 5.07 |
MCF-7 | 35.4 | 5.24 |
Cytotoxicity activities (IC50) of AgNPs against hepatocellular cancer (HepG-2) and breast cancer cells (MCF-7).
Cell Lines | IC50 µg/mL | |
---|---|---|
AgNPs | Doxorubicin | |
HepG2 | 7.6 | 5.07 |
MCF-7 | 35.4 | 5.24 |